Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/1996
11/13/1996EP0741740A1 Method of preparing unsymmetrical phosphoric acid diesters and salts
11/13/1996CN1033272C Method of producing 5'-nucleotide
11/12/1996US5574149 Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine
11/12/1996US5574148 Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides
11/12/1996US5574146 Oligonucleotide synthesis with substituted aryl carboxylic acids as activators
11/12/1996US5574058 Polysubstituted benzimidazoles as antiviral agents
11/12/1996US5574021 Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosides
11/12/1996US5573946 Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds
11/07/1996WO1996034876A1 Nucleic acid ligand complexes
11/06/1996CN1033227C Method for prepn. of pyrimidine nucleoside derivatives having anti-tumor activity
11/05/1996US5571937 Complementary DNA and toxins
11/05/1996US5571902 Synthesis of oligonucleotides
11/05/1996US5571799 (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
11/05/1996US5571670 Nucleic acid probes useful in detecting Chlamydia trachomatis and amplified nucleic acid hybridization assays using same
11/05/1996US5571524 Diadenosine tetraphosphate
10/1996
10/30/1996EP0739902A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739901A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739900A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739899A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use
10/29/1996US5569650 Dehydrogenase enzyme inhibitor
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996033200A1 Novel compounds and methods for therapy
10/23/1996EP0738274A1 Novel nucleoside-lipid addition compounds, their production and their pharmaceutical use
10/23/1996EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
10/23/1996EP0738272A1 Method and separation substrate for analysing mononucleotides and oligonucleotides
10/22/1996US5567720 Pharmaceutically active agents that impede amyloid formation in vivo
10/22/1996US5567688 L-nucleosides for the treatment of hepatitis B-virus
10/22/1996US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification
10/17/1996WO1996032496A2 Covalently linked oligonucleotide minor groove binder conjugates
10/17/1996WO1996032404A1 Amphiphilic polyene macrolide antibiotic compounds
10/17/1996WO1996032403A2 Novel cytosine and cytidine derivatives
10/17/1996DE19514523A1 Neue Cytosin- und Cytidinderivate New cytosine and Cytidinderivate
10/16/1996EP0737232A1 Modular design and synthesis of aminimide containing molecules
10/16/1996EP0737201A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
10/15/1996US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting
10/15/1996US5565555 Oligonucleotide synthesis; viricides; anticarcinogenic agents; medical diagnosis
10/15/1996US5565438 L-nucleosides for the treatment of epstein-bar virus
10/15/1996US5565437 Aids treatment
10/15/1996US5565359 Cultures for production of B avermectins
10/10/1996WO1996031523A1 Covalently cross-linked oligonucleotides, method for preparing same, and synthon used therein
10/10/1996WO1996031520A2 Novel method of producing nucleosides
10/10/1996WO1996031515A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/10/1996WO1996031514A1 Ascomycins
10/10/1996DE19513330A1 Neues Verfahren zur Herstellung von Nucleosiden New process for the preparation of nucleosides
10/10/1996CA2216562A1 Ascomycins
10/10/1996CA2215111A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/08/1996US5563257 Phospholipid derivatives of nucleosides
10/08/1996US5563172 Macrocyclic amide and urea immunomodulators
10/08/1996US5563135 Immunosuppressive agent
10/08/1996US5563125 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pharmaceutical compositions
10/08/1996US5563049 Culture product
10/03/1996WO1996030369A1 Process for the synthesis of nucleoside analogues
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/02/1996EP0735045A1 Process for the preparation of 2,2'-andhydro- and 2'-keto-1-(3',5'-di-o-protected-beta -d-arabinofuranosyl) nucleosides
10/02/1996EP0735044A1 Preparation of D4T from 5-methyluridine
10/02/1996EP0735043A1 Process for the preparation of a 2-substituted-3,3-difluorofuran
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996CN1132529A DNA sequencing enzymes
10/02/1996CN1132513A Process and antiparasitic intermediates for doramectin
10/02/1996CN1132073A 1,3-oxathiolane nucleoside analogues
10/01/1996US5561228 Immunosuppressnats; side effect reduction
10/01/1996US5561225 Phosphorus-free nucleotides, oligonucleotides and polynucleotides having sulfonate or sulfonamide linkages; antisense agents; anticarcinogenic agents; parasiticides; genetic probes; hiv
10/01/1996US5561137 Immunosuppressants; side effect reduction
10/01/1996US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/01/1996US5561120 Low toxicity to host cells
09/1996
09/26/1996WO1996029345A1 Novel inotropic agents
09/26/1996WO1996029336A1 Chemical compounds
09/25/1996EP0733630A1 Nucleoside derivative
09/25/1996EP0733214A1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto
09/25/1996EP0733119A1 Method of producing derivatives of lactosamine
09/25/1996CA2171522A1 Process for the preparation of a 2-substituted-3, 3-difluorofuran
09/25/1996CA2171518A1 Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
09/24/1996US5559222 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
09/24/1996US5559102 Adenosine and guanosine-3'-5'-cyclic methylphosphonate derivatives
09/24/1996US5559101 Antitumor, anticarcinogenic, hiv
09/24/1996US5559100 Viricides using aminopurine bases
09/24/1996US5558991 DNA sequencing method using acyclonucleoside triphosphates
09/24/1996US5558986 Method and kit for ATP assays using cyclodextrin
09/19/1996WO1996028457A1 Nucleic acid synthesis using photoremovable protecting groups
09/19/1996WO1996028438A1 Non-nucleosidic coumarin derivatives as polynucleotide-cross-linking agents
09/19/1996WO1996028170A1 Reduced toxicity compositions and methods for treating hiv infections
09/19/1996WO1996028163A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996WO1996018736A3 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
09/19/1996CA2215657A1 Nucleic acid synthesis using photoremovable protecting groups
09/19/1996CA2214835A1 Non-nucleosidic coumarin derivatives as polynucleotide-cross-linking agents
09/19/1996CA2213749A1 Adenosine as a positive inotrop in the compromised heart
09/18/1996EP0732338A1 2,2-Difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
09/18/1996EP0731808A1 Nucleosides and oligonucleotides containing boron clusters
09/18/1996EP0731807A1 N-2 substituted purines
09/17/1996US5556975 Cyclic gmp phosphodiesterase inhibitor
09/17/1996US5556961 Nucleosides with 5'-O-photolabile protecting groups
09/17/1996US5556868 Antiparasitic avermectin and milbemycin derivatives
09/12/1996WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
09/12/1996WO1996027605A1 Systematic evolution of ligands by exponential enrichment: chemi-selex
09/12/1996WO1996027380A1 Reduction of infarct volume using citicoline
09/12/1996CA2213000A1 Reduction of infarct volume using citicoline
09/12/1996CA2209665A1 Systematic evolution of ligands by exponential enrichment: chemi-selex
09/11/1996EP0542952B1 Use of 1-(beta-d-arabinofuranosyl)-5-propynyluracil for lowering serum cholesterol